We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OCX market cap is 35.86M. The company's latest EPS is USD -1.7061 and P/E is -1.25.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 864k | -10.87M | 176k | 104k | 115k |
| Operating Income | 248k | -22.94M | -9.1M | -4.63M | -13.52M |
| Net Income | -7.23M | -16.2M | -9.13M | -4.53M | -13.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 5.23M | 7.73M | 31.98M | 7.27M |
| Operating Income | -22.52M | -31.26M | -74.48M | -18M | -23.85M |
| Net Income | -22.43M | -29.93M | -64.1M | -73.42M | -28.72M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 81.59M | 74.89M | 70.97M | 74.72M | 70.22M |
| Total Liabilities | 39.1M | 49.3M | 54.05M | 52.02M | 60.51M |
| Total Equity | 37.56M | 20.47M | 11.59M | 22.7M | 9.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.86M | 55.42M | 159.56M | 100.09M | 74.89M |
| Total Liabilities | 9.02M | 21.94M | 94.35M | 60.5M | 49.3M |
| Total Equity | 30.84M | 33.48M | 65.22M | 34.29M | 20.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.76M | -23.33M | -3.83M | -9.81M | -15.36M |
| Investing | -1.17M | -932k | -24k | -215k | -302k |
| Financing | 12.22M | 12.19M | N/A | 9.85M | 9.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.72M | -25.98M | -35.94M | -45.57M | -23.33M |
| Investing | -12.42M | -11.75M | -13.96M | -4.34M | -932k |
| Financing | 47.87M | 22.8M | 78.36M | 35.81M | 12.19M |
| Market Cap | 35.86M |
| Price to Earnings Ratio | -1.25 |
| Price to Sales Ratio | 4.94 |
| Price to Cash Ratio | 3.8 |
| Price to Book Ratio | 1.4 |
| Dividend Yield | - |
| Shares Outstanding | 16.84M |
| Average Volume (1 week) | 93.06k |
| Average Volume (1 Month) | 56.42k |
| 52 Week Change | -29.24% |
| 52 Week High | 3.4799 |
| 52 Week Low | 1.922 |
| Spread (Intraday) | 0.07 (3.29%) |
| Company Name | Oncocyte Corporation |
| Address |
15 cushing irvine, california 92618 |
| Website | https://www.oncocyte.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
